[Pharmacological and clinical profile of finasteride (PROPECIA)].
Fukuzumi
Hitoshi
H
hitoshi_fukuzumi@merck.com
Ikeda
Takanori
T
Narita
Hirohisa
H
Takubo
Takatoshi
T
Matsuda
Takuma
T
Taniguchi
Tadaaki
T
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000172:deficiency / Q000235:genetics; D058891:5-alpha Reductase Inhibitors; D000505:Alopecia / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D002986:Clinical Trials as Topic; D013196:Dihydrotestosterone / Q000378:metabolism; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D018120:Finasteride / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000882:Haplorhini; D006801:Humans; D008297:Male
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase